Skip to main content
. 2022 Aug 11;5:876100. doi: 10.3389/frai.2022.876100

Table 1.

Patient and tumor characteristics.

TNBC cases Controls
N 88 167
Age, mean +/– SD 50 +/– 11 58 +/– 9
Stage, N (%)
 I 9 (10)
 II 64 (73)
 III 15 (17)
RCB status, N (%)
 0 48 (55)
 I 14 (16)
 II 21 (24)
 III 5 (6)

†All TNBC patients received NACT; plasma samples were collected pre-treatment.

TNBC, triple-negative breast cancer; RCB, Residual Cancer Burden.